New content: CRISPR & Sickle Cell
I'm very excited to announce brand new content: an exploration of potential CRISPR treatments for sickle cell disease. This experience is the result of a wonderful collaborative effort between Dynamoid and our UC Berkeley partners - the Innovative Genomics Institute and Lawrence